Clinical Data

Goal disorientation and lack of vision
Biotech

Evommune’s phase 2b flops, ending challenge to Novartis in hives

A phase 2b trial of Evommune’s EVO756 has missed its primary endpoint, wiping out a would-be rival to Novartis for a skin disease market.
Nick Paul Taylor Jun 29, 2026 10:00am
An arrow incrementally going up stairs before pointing straight up Blue background

Otsuka posts phase 3b ADHD trial win ahead of looming FDA ruling

Jun 25, 2026 9:13am
Moderna

FDA appears less prickly toward Moderna mRNA flu shot

Jun 16, 2026 2:46pm
Heart and stethoscope isolated on blue background concept for healthcare and diagnosis medical cardiac pulse test

Edgewise data power rival to BMS and Cytokinetics toward phase 3

Jun 16, 2026 10:39am
NVS

Novartis dystrophy data tee up regulatory talks on Avidity drug

Jun 12, 2026 4:30am
Sanofi

Sanofi halts phase 3 autoimmune trial early over lackluster data

Jun 10, 2026 4:25am